Published on 05/12/2025
Top 10 Warning Signs Your Combined & Companion QMS for Medical Devices & Combination Products Approach Will Fail an Audit
In the regulated environments of medical devices and combination products, the establishment of a robust Quality Management System (QMS) is paramount. A combined & companion QMS for medical devices & combination products must align with the stringent requirements set forth by regulatory bodies such as the FDA, EMA, and ISO. This article serves as a comprehensive tutorial, guiding quality managers, regulatory affairs, and compliance professionals through the critical steps to ensure their QMS is audit-ready. We will explore the top ten warning signs that may indicate your QMS is
Step 1: Understanding Regulatory Requirements
The first phase in establishing an effective combined & companion QMS for medical devices & combination products is to thoroughly understand the regulatory requirements. This involves familiarizing yourself with the relevant guidelines issued by the FDA, EMA, and ISO standards.
Objectives: Ensure that your QMS is designed to meet all applicable regulatory requirements, thereby minimizing the risk of non-compliance.
Documentation: Maintain a comprehensive library of regulatory documents, including FDA 21 CFR Part 820 for medical devices, ISO 13485:2016, and relevant EMA guidelines.
Roles: Quality managers should lead this effort, with input from regulatory affairs professionals to ensure all aspects of compliance are covered.
Inspection Expectations: During inspections, auditors will review your understanding of regulatory requirements and how they are integrated into your QMS. They will look for documented evidence of training and awareness among staff.
Example: A medical device manufacturer that fails to keep up with changes in FDA regulations may find itself in a precarious position during an audit, as outdated practices can lead to non-compliance.
Step 2: Risk Management Framework
Implementing a robust risk management framework is essential for any combined & companion QMS. This framework should identify, assess, and mitigate risks associated with the product lifecycle.
Objectives: To proactively manage risks that could impact product quality and patient safety.
Documentation: Develop a risk management plan that includes risk assessments, mitigation strategies, and a risk register.
Roles: Quality assurance teams should collaborate with product development and regulatory affairs to ensure comprehensive risk management.
Inspection Expectations: Auditors will expect to see a systematic approach to risk management, including documented assessments and actions taken to mitigate identified risks.
Example: A combination product manufacturer may identify potential risks in the interaction between drug and device components, necessitating thorough testing and validation processes.
Step 3: Training and Competence
Ensuring that all personnel involved in the QMS are adequately trained and competent is crucial for compliance. Training programs should be tailored to the specific needs of the organization and the regulatory environment.
Objectives: To ensure that employees understand their roles within the QMS and are equipped to perform their tasks effectively.
Documentation: Maintain training records, including training plans, attendance logs, and competency assessments.
Roles: Quality managers should oversee training initiatives, while department heads ensure that their teams are adequately trained.
Inspection Expectations: Auditors will review training records and may conduct interviews to assess employee understanding of their roles and responsibilities.
Example: A quality manager at a medical device company might discover that new employees are not adequately trained on the QMS, leading to inconsistencies in quality practices.
Step 4: Document Control
Effective document control is a cornerstone of a successful QMS. All documents should be properly managed to ensure that the most current versions are in use and that obsolete documents are removed from circulation.
Objectives: To maintain the integrity and availability of quality documents.
Documentation: Implement a document control procedure that outlines how documents are created, reviewed, approved, and archived.
Roles: Quality assurance personnel should manage document control, while all employees must adhere to the established procedures.
Inspection Expectations: Auditors will examine document control processes and may request to see how documents are managed and accessed.
Example: A company that fails to control its design documents may inadvertently use outdated specifications, leading to product defects and regulatory penalties.
Step 5: Change Control Process
Changes to processes, products, or systems must be managed through a formal change control process to ensure that any potential impacts on quality are assessed and addressed.
Objectives: To minimize the risk of unintended consequences resulting from changes.
Documentation: Develop a change control procedure that includes a change request form, impact assessment, and approval process.
Roles: All departments involved in product development and manufacturing should participate in the change control process.
Inspection Expectations: Auditors will review change control records to ensure that changes were properly evaluated and documented.
Example: A change in supplier for a critical component without proper assessment could lead to product failures, resulting in significant compliance issues.
Step 6: Internal Audits
Regular internal audits are essential for identifying non-conformities and areas for improvement within the QMS. These audits should be planned and executed systematically.
Objectives: To evaluate the effectiveness of the QMS and ensure compliance with regulatory requirements.
Documentation: Maintain an internal audit schedule, audit reports, and corrective action plans.
Roles: A dedicated internal audit team should conduct audits, while management is responsible for addressing findings.
Inspection Expectations: Auditors will review internal audit reports and corrective actions taken to address identified issues.
Example: A company that neglects internal audits may miss critical compliance gaps, leading to significant findings during external audits.
Step 7: Management Review
Management reviews are a crucial component of an effective QMS, providing a forum for evaluating the performance of the system and making strategic decisions.
Objectives: To ensure that the QMS is aligned with organizational goals and is continuously improving.
Documentation: Document the management review process, including agendas, minutes, and action items.
Roles: Senior management should lead the review, with input from quality managers and department heads.
Inspection Expectations: Auditors will expect to see evidence of management involvement and commitment to the QMS.
Example: A lack of management review may indicate a disconnect between quality objectives and overall business strategy, leading to compliance issues.
Step 8: Corrective and Preventive Actions (CAPA)
A robust CAPA process is essential for addressing non-conformities and preventing their recurrence. This process should be well-defined and integrated into the QMS.
Objectives: To identify root causes of non-conformities and implement effective corrective actions.
Documentation: Maintain CAPA records, including investigation reports, root cause analyses, and action plans.
Roles: Quality assurance teams should lead CAPA investigations, while all departments must participate in implementing corrective actions.
Inspection Expectations: Auditors will review CAPA records to assess the effectiveness of the process and the timeliness of actions taken.
Example: A company that fails to address recurring quality issues may face severe penalties during an audit, as it indicates a lack of commitment to compliance.
Step 9: Supplier Management
Effective supplier management is critical for ensuring that all external inputs meet quality standards. This includes evaluating and monitoring supplier performance.
Objectives: To ensure that suppliers consistently provide materials and services that meet quality requirements.
Documentation: Develop a supplier evaluation and monitoring procedure, including criteria for selection and performance metrics.
Roles: Procurement and quality assurance teams should collaborate to manage supplier relationships.
Inspection Expectations: Auditors will review supplier management records to ensure that suppliers are adequately evaluated and monitored.
Example: A failure to properly assess a new supplier could lead to the introduction of substandard materials, resulting in compliance issues.
Step 10: Continuous Improvement
The final step in ensuring a successful combined & companion QMS is to foster a culture of continuous improvement. This involves regularly evaluating processes and seeking opportunities for enhancement.
Objectives: To enhance the effectiveness and efficiency of the QMS over time.
Documentation: Maintain records of improvement initiatives, including project plans and outcomes.
Roles: All employees should be encouraged to contribute ideas for improvement, with quality managers facilitating the process.
Inspection Expectations: Auditors will look for evidence of continuous improvement efforts and their impact on the QMS.
Example: A company that actively seeks feedback from employees and customers may identify innovative solutions that enhance product quality and compliance.
Conclusion
Establishing a combined & companion QMS for medical devices & combination products is a complex but essential task for ensuring compliance with regulatory requirements. By following the steps outlined in this tutorial, quality managers, regulatory affairs, and compliance professionals can identify potential warning signs that may lead to audit failures and take proactive measures to address them. Continuous monitoring and improvement of the QMS will not only enhance compliance but also contribute to the overall success of the organization.